机译:标准治疗的随机期III试验加低分子量肝素肺癌患者:Fragmatic试验
Wales Canc Trials Unit Cardiff S Glam Wales;
Cardiff Univ Cardiff CF10 3AX S Glam Wales;
Wales Canc Trials Unit Cardiff S Glam Wales;
Wales Canc Trials Unit Cardiff S Glam Wales;
Univ New S Wales Cardiff S Glam Wales;
Cardiff Univ Cardiff CF10 3AX S Glam Wales;
Prince Charles Hosp Merthyr Tydfil M Glam Wales;
Beaumont Hosp Dublin 9 Ireland;
Univ New S Wales Cardiff S Glam Wales;
Natl Inst Social Care &
Hlth Res Clin Res Ctr Cardiff S Glam Wales;
Weston Pk Hosp Sheffield S Yorkshire England;
Royal Preston Hosp Preston Lancs England;
Mt Vernon Canc Ctr Northwood Middx England;
Royal Wolverhampton Hosp Natl Hlth Serv Trust Wolverhampton W Midlands England;
Mid Staffordshire Hosp Stafford England;
Wales Canc Trials Unit Cardiff S Glam Wales;
机译:肺癌患者标准疗法加低分子量肝素的随机III期试验:FRAGMATIC试验
机译:低分子量肝素依从性和对随机期III肺癌试验中存活的影响(RASTEN)
机译:FRAGMATIC:一项随机的III期临床试验,研究了fragm对?肺癌患者的标准治疗
机译:共生疗法可显着降低活动性结肠炎患者的炎症分子标记和临床评分;随机对照试验
机译:涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募,保留和依从性报告。
机译:低分子量肝素依诺肝素和标准疗法在小细胞肺癌中的随机III期试验:RASTEN试验
机译:标准疗法加低分子肝素治疗肺癌患者的随机III期试验:FRaGmaTIC试验